November 4, 2024
To | To |
Listing Department, | The Corporate Relations Department |
NATIONAL STOCK EXCHANGE OF INDIA LIMITED | BSE LIMITED |
Exchange Plaza, | Phiroz Jeejeebhoy Towers, |
Bandra Kurla Complex, Bandra (E), | 25th floor, Dalal Street, |
MUMBAI -400 051 | MUMBAI -400 001 |
Company Code No. AUROPHARMA | Company Code No. 524804 |
Dear Sir/Madam, | |
Sub: Analyst / Investor call |
Pursuant to Regulation 30(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the schedule of Earnings Call to be held on November 11, 2024, at 8:30 AM (IST) on Unaudited Financial Results of the Company for the second quarter and half year ended September 30, 2024.
Thanking you,
Yours faithfully,
For AUROBINDO PHARMA LIMITED
BADDIGA Digitally signed | |
M ADI | by BADDIGAM |
ADI REDDY | |
REDDY | Date: 2024.11.04 |
10:24:32 +05'30' |
B. Adi Reddy
Company
Encl: as above
Corp. Off.: Galaxy, Floors: 22-24, Plot No.1, Survey No.83/1, Hyderabad Knowledge City, Raidurg Panmaktha, Ranga Reddy District, Hyderabad - 500 032, Telangana, India.
Tel : +91 40 6672 5000 / 6672 1200 Fax: +91 40 6707 4044.
Regd. off.: PlotNo. 2, Maithrivihar, Ameerpet, Hyderabad - 500038 T.S., INDIA Tel:+91 4023736370/ 23747340 Fax: +914023741080 / 23746833 Email: info@aurobindo.com Website: www.aurobindo.com